Presented at the 29th European Academy of Dermatology and Venereology (EADV) Congress (2020)
Collaborator: Scientific committee
Authors: B. HALIOUA, J. ZETLAOUI, R. KANENGIESER, E. PAIN, T. LÉVY-HEIDMANN, L. RADOSZYCKI
This study was made during the outbreak of coronavirus disease 2019 (COVID19) pandemic known as COVID-19. The virus has spread over 200 countries, affecting more than 35 million people and causing over than 1 000 000 deaths. Consequences have arisen for the clinical outcomes of patients with psoriasis as well as obstacles to regular access to healthcare and taking long-term medications.
Objective: Evaluation of the impact of the COVID-19 outbreak on patients with psoriasis using an online patient community.
